Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Email this article to a friend

Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma

Martina Mayr, Karen Becker, Nadine Schulte, Sebastian Belle, Ralf Hofheinz, Annekatrin Krause, Roland M Schmid, Christoph Röcken and Matthias P Ebert*

BMC Cancer 2012, 12:587  doi:10.1186/1471-2407-12-587

Fields marked * are required

Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?